From October 1, 2022 to December 15, 2022, the company has repurchased 394,400 shares, representing 0.11% for CNY 9.28 million. With this, the company has completed the repurchase of 2,403,643 shares, representing 0.69% for CNY 58 million under the buyback announced on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.63 CNY | -1.85% | -4.71% | -9.58% |
06/05 | China Approves Tianyu Pharma's Heart Medication | MT |
26/04 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.58% | 93Cr | |
+18.25% | 4.22TCr | |
+15.37% | 2.13TCr | |
+19.40% | 1.52TCr | |
+19.55% | 1.44TCr | |
+51.64% | 1.27TCr | |
-0.05% | 678.76Cr | |
-12.40% | 660.77Cr | |
-8.87% | 572.55Cr | |
+14.28% | 565.61Cr |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 30, 2022.